Document Classification

Section Type: METHODS

Text: From Jul. 2008 to Dec. 2009, 109 women with low bone mineral density (BMD) or osteoporosis treated in Department of Obstetrics and Gynecology, Affiliated Second Hospital, Wenzhou Medical College were enrolled randomly into 3 group, including 36 women in Group A managed by osteoform 1000 mg/d + alfacalcidol 0. 25 g/bid orally, 40 women in group B managed by osteoform 1000 mg/d + alfacalcidol 0. 25 g/bid + tibolone 1. 25 mg/d orally and 33 women in group C managed by osteoform 1000 mg/d + alfacalcidol 0. 25 g/bid + bisphosphonates 70 mg/w orally.